which could be a concern for those interested in Zepbound. A spokesperson from Eli Lilly addressed this issue. “Today we are able to meet demand, but realize we will face challenges. We do our ...

As GLP-1 medications like Ozempic, Wegovy, Zepbound, and Mounjaro gain popularity, doctors are observing a surge in patients ...

Zepbound, which was only introduced in November ... on Eli Lilly’s sales growth Part of the problem both pharmas face has been availability. Demand had been so great that they were having ...